Answer Posted / ramireddy
THE DRUG SUBSTANCE HAS ACTIVE IN NATURE. IF WE ARE TAKING
IN SMALL AMOUNTS AT THE TIME OF DISEASE THAT SHOWS VERY
EFFECTIVE TO OUR BODY THE DRUG PRODUCT HAS HIGH PURITY
THAT IS ONLY USED FOR HUMAN BEINGS , AS PER ICH GUIDELINES
THE IMPURITY LEVEL IS SHOULD BE LESS THAN 0.1% ONLY THAT
DRUGS WE ARE USED FOR CURE OF ANY DISEASES BECASUSE THAT
HAS HIGH PURITY.
| Is This Answer Correct ? | 1 Yes | 4 No |
Post New Answer View All Answers
how to select short coloum and long coloumn for new molecule
How to choose the which salt is suitable for mobilephase
A ha tc is actual defination of retention time?
What is diffrence between extractable volume and deliverable volume? Answer pls
How to decide assay range for non pharmacopeial API analysis by HPLC? Could you give me any reference for same e.g Guidelines or Paper publications?
Why are use silicon oil mr?
How we can identify process related and degradation impurity in single method with short period?
What are the primary considerations in extractables and Leachables ?
In GC calibration,what is the procedure to calibrate the TCD (thermal counductivity detector)suggest ?
some product having water content method with pyridine and ethylene glycol mixture instead of methanol? how they are selecting and methanol is not suitable solvent how ?
How can we calculate "confidence interval" in analytical method validation? Pl. explain with example.
How require to perform linearity as per ANVISA? What are the acceptance criteria?
if you have given a blank water how you analyse by general analytical techniques?
If we do accuracy at same concentration at which linearity planned,what is the need to do linearity separately?
What is mean by PDR?
